Which has higher valuation and earnings, APLMW or ALVOW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Apollomics $8.50M N/A N/A N/A N/A Alvotech $491.95M N/A N/A N/A N/A

Is APLMW or ALVOW more profitable?

Company Net Margins Return on Equity Return on Assets Apollomics N/A N/A N/A Alvotech N/A N/A N/A

Which has preferable earnings and valuation, APLMW or ARAV?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Apollomics $8.50M N/A N/A N/A N/A Aravive N/A N/A N/A -$0.90 N/A

Is APLMW or ARAV more profitable?

Company Net Margins Return on Equity Return on Assets Apollomics N/A N/A N/A Aravive N/A N/A N/A

Which has preferable valuation & earnings, APLMW or BIAFW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Apollomics $8.50M N/A N/A N/A N/A bioAffinity Technologies $5.85M N/A N/A N/A N/A

Is APLMW or BIAFW more profitable?

Company Net Margins Return on Equity Return on Assets Apollomics N/A N/A N/A bioAffinity Technologies N/A N/A N/A

Which has higher valuation and earnings, BIVIW or APLMW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio BioVie N/A N/A N/A N/A N/A Apollomics $8.50M N/A N/A N/A N/A

Is BIVIW or APLMW more profitable?

Company Net Margins Return on Equity Return on Assets BioVie N/A N/A N/A Apollomics N/A N/A N/A

Which has preferable valuation & earnings, CDIOW or APLMW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cardio Diagnostics $14.45K N/A N/A N/A N/A Apollomics $8.50M N/A N/A N/A N/A

Is CDIOW or APLMW more profitable?

Company Net Margins Return on Equity Return on Assets Cardio Diagnostics N/A N/A N/A Apollomics N/A N/A N/A

Apollomics (APLMW) Competitors

$0.01 0.00 (0.00%)

As of 09/2/2026 01:29 PM Eastern

Compare

APLMW vs. ALVOW, ARAV, BIAFW, BIVIW, and CDIOW

Should you buy Apollomics stock or one of its competitors? Apollomics's main competitors and comparable companies include Alvotech (ALVOW), Aravive (ARAV), bioAffinity Technologies (BIAFW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Apollomics compare to Alvotech?

Apollomics (NASDAQ:APLMW) and Alvotech (NASDAQ:ALVOW) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, media sentiment, risk, dividends, earnings and institutional ownership.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apollomics	$8.50M	N/A	N/A	N/A	N/A
Alvotech	$491.95M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Apollomics	N/A	N/A	N/A
Alvotech	N/A	N/A	N/A

In the previous week, Alvotech had 1 more articles in the media than Apollomics. MarketBeat recorded 1 mentions for Alvotech and 0 mentions for Apollomics. Alvotech's average media sentiment score of 0.92 beat Apollomics' score of 0.00 indicating that Alvotech is being referred to more favorably in the news media.

Company	Overall Sentiment
Apollomics	Neutral
Alvotech	Positive

Summary

Alvotech beats Apollomics on 3 of the 3 factors compared between the two stocks.

How does Apollomics compare to Aravive?

Apollomics (NASDAQ:APLMW) and Aravive (NASDAQ:ARAV) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, valuation, profitability, risk, analyst recommendations, media sentiment and institutional ownership.

Company	Net Margins	Return on Equity	Return on Assets
Apollomics	N/A	N/A	N/A
Aravive	N/A	N/A	N/A

In the previous week, Apollomics' average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company	Overall Sentiment
Apollomics	Neutral
Aravive	Neutral

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apollomics	$8.50M	N/A	N/A	N/A	N/A
Aravive	N/A	N/A	N/A	-$0.90	N/A

Summary

Aravive beats Apollomics on 2 of the 3 factors compared between the two stocks.

How does Apollomics compare to bioAffinity Technologies?

Apollomics (NASDAQ:APLMW) and bioAffinity Technologies (NASDAQ:BIAFW) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

Company	Net Margins	Return on Equity	Return on Assets
Apollomics	N/A	N/A	N/A
bioAffinity Technologies	N/A	N/A	N/A

In the previous week, bioAffinity Technologies had 2 more articles in the media than Apollomics. MarketBeat recorded 2 mentions for bioAffinity Technologies and 0 mentions for Apollomics. Apollomics' average media sentiment score of 0.00 beat bioAffinity Technologies' score of -0.66 indicating that Apollomics is being referred to more favorably in the media.

Company	Overall Sentiment
Apollomics	Neutral
bioAffinity Technologies	Negative

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apollomics	$8.50M	N/A	N/A	N/A	N/A
bioAffinity Technologies	$5.85M	N/A	N/A	N/A	N/A

Summary

Apollomics beats bioAffinity Technologies on 2 of the 3 factors compared between the two stocks.

How does Apollomics compare to BioVie?

BioVie (NASDAQ:BIVIW) and Apollomics (NASDAQ:APLMW) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability and analyst recommendations.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioVie	N/A	N/A	N/A	N/A	N/A
Apollomics	$8.50M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
BioVie	N/A	N/A	N/A
Apollomics	N/A	N/A	N/A

In the previous week, BioVie had 1 more articles in the media than Apollomics. MarketBeat recorded 1 mentions for BioVie and 0 mentions for Apollomics. BioVie's average media sentiment score of 0.00 equaled Apollomics'average media sentiment score.

Company	Overall Sentiment
BioVie	Neutral
Apollomics	Neutral

Summary

BioVie and Apollomics tied by winning 1 of the 2 factors compared between the two stocks.

How does Apollomics compare to Cardio Diagnostics?

Cardio Diagnostics (NASDAQ:CDIOW) and Apollomics (NASDAQ:APLMW) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

Company	Net Margins	Return on Equity	Return on Assets
Cardio Diagnostics	N/A	N/A	N/A
Apollomics	N/A	N/A	N/A

In the previous week, Cardio Diagnostics' average media sentiment score of 0.00 equaled Apollomics'average media sentiment score.

Company	Overall Sentiment
Cardio Diagnostics	Neutral
Apollomics	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardio Diagnostics	$14.45K	N/A	N/A	N/A	N/A
Apollomics	$8.50M	N/A	N/A	N/A	N/A

Summary

Apollomics beats Cardio Diagnostics on 1 of the 1 factors compared between the two stocks.

Get Apollomics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APLMW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

APLMW vs. The Competition

Export

Metric	Apollomics	Biotechnology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$4.03B	$7.26B	$12.73B
Dividend Yield	N/A	3.60%	2.53%	8.86%
P/E Ratio	N/A	12.66	273.30	25.25
Price / Sales	N/A	1,324.01	617.95	97.64
Price / Cash	N/A	106.87	77.82	52.26
Price / Book	N/A	16.69	13.03	6.14
Net Income	N/A	-$22.72M	$3.47B	$349.01M
7 Day Performance	N/A	0.16%	0.52%	-0.31%
1 Month Performance	N/A	8.30%	5.63%	0.64%
1 Year Performance	N/A	52.64%	25.32%	14.83%

Apollomics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
APLMW Apollomics	N/A	$0.01 flat	N/A	+42.3%	$0.00	$8.50M	N/A	59	Gap Down
ALVOW Alvotech	N/A	$0.30 flat	N/A	-73.0%	$0.00	$491.95M	N/A	4
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
BIAFW bioAffinity Technologies	N/A	$0.10 +37.2%	N/A	+1,001.7%	$0.00	$5.85M	N/A	10
BIVIW BioVie	N/A	$0.29 +2.5%	N/A	N/A	$0.00	N/A	N/A	N/A	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:APLMW) was last updated on 9/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Apollomics (APLMW) Competitors